Trieu Vuong 4
4 · Oncotelic Therapeutics, Inc. · Filed Jul 10, 2025
Insider Transaction Report
Form 4
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
- Purchase
Common Stock
2025-07-10$0.01/sh+104,000$520→ 93,293,560 total - Purchase
Common Stock
2025-07-09$0.01/sh+1$0→ 93,293,561 total - Purchase
Common Stock
2025-07-08$0.01/sh+94,736$474→ 93,388,297 total
Holdings
- 16,780,384(indirect: By Autotelic, Inc.)
Common Stock
- 6,872,529(indirect: By Spouse)
Common Stock